Myodetox’s Post

So true. The way a team interacts with each other is strongly predictive on multiple levels.

A little pasta humour to get us in the mood for Ophthalpreneurs 🍝 😉 ! Seriously, though: studies show that 𝟭 𝗶𝗻 𝟰 𝗱𝗼𝗰𝘁𝗼𝗿𝘀, regardless of the stage in their career, grapple with imposter syndrome. If you happen to be that one, you can confidently leave it behind when you come to Stresa. Why? Because at Ophthalpreneurs, you're part of special community committed to revolutionizing private and patient-pay ophthalmology. Every single attendee, including you, is a vital piece of this puzzle, armed with unique insights, experiences, and innovations. Remember, you're attending because you've already made significant strides in your journey, showcasing your dedication, your expertise, and your entrepreneurial spirit. Ophthalpreneurs isn't just a gathering; it's a celebration of those achievements and a testament to your potential to shape the industry. So, ditch the doubt and let's get ready to drive change together!

🌟 Looking forward to seeing everyone at the Advanced Therapies Congress in London over the next few days! 🤝 We’ve got a brilliant couple of days lined up for you, filled with thought provoking talks, discussions, workshops, roundtables, networking, an exhibition full of cool booths, tech, start-ups, posters, you might even have some fun! 🏥 The theme of this year’s conference is about how we tackle each stage of development to bring these incredible therapies to treat patients in need. 💊 We’ve put together the agenda to look at each of the fundamental hurdles in commercial development which still need to be perfected: tackling manufacturing issues, clinical development and trials, looking at commercial sustainability, how to improve the supply chain, evidence, pricing and patient access. 🙏 Thanks to all our sponsors, speakers, partners, start-ups and attendees for making this, very much for making this, what I can confidently say, will be the best Advanced Therapies Congress yet 😎 Advanced Therapies Congress #AdTherapies24

Business Finland and Mayo Clinic Ventures have a new strategic partnership to develop and explore opportunities for collaboration. Among various activities, we want to explore how might we help Finnish companies to gain investments for growth and experience in the US? Also, how might we expand Mayo's global collaborations to tap into innovations in Finland? Very exciting. You can hear more about it at this webinar later this week. #finland #healthcare #mayoclinic

Check out my interview with Virginia Technology Today below.

We are celebrating the successful closing of an additional $2.32 Million in Seed Plus funding, closing this round out $500,000 oversubscribed at $5 Million to address underserved #pelvichealth issues. This milestone reflects progress toward our mission to empower women & clinicians with a new gold standard in conservative care for #urinaryincontinence. We extend our deep appreciation to our outstanding partner, Boomerang Ventures for leading this investment round, and we warmly welcome new investors Pier 70 Ventures, Life Science Angels, Orange County Tech Coast Angels MedTech, and Blue Pacific Capital! "Completing this round is an important step in continuing Pelvital's unwavering dedication to provide women with innovative solutions for pelvic health, including the treatment of SUI," says Lydia Zeller, President and CEO of Pelvital. "This funding will play a crucial role in accelerating our commercialization of Flyte with a strong emphasis on expanding payor coverage, enhancing clinical education and clinician awareness, and advocating for upstream screening for UI in primary care and OB/GYN." With this close we are honored to welcome Preetha Ram, PhD, Managing Partner at Pier 70 Ventures, to the Pelvital Board of Directors.   "Joining Pelvital's Board alongside this investment round is truly an honor," she shares. "Pier 70 and I are thrilled to be part of this transformational opportunity, as Pelvital's mission aligns beautifully with our dedication to support disruptive technologies that shake up the status quo in healthcare. Pelvital's pioneering work is shaping a future where women's health receives the attention and innovation it deserves with novel medical devices like Flyte." With two published clinical trials validating Flyte's efficacy, we're excited to offer a groundbreaking treatment option for women. Learn more at Flytetherapy.com. #funding #Innovation #WomenInHealthcare Read the full release here: https://lnkd.in/ggkavYRq

👓✨ Transforming eye care for the better! Discover how RetinaLogik is revolutionizing vision health with groundbreaking technology, making accurate and affordable eye exams accessible to all. Ready to see the future of eye care? 👉️Dive into our latest blog to learn more about this visionary effort. https://lnkd.in/gQKjzva9 Written by Lisa van de Geyn #OntarioAngels #CanadianStartups #InnovationNation #AngelInvesting #BusinessSuccess #EyeCareInnovation #RetinaLogik #VisionHealth 🌟

🌟 Empowering Physician Entrepreneurs to Innovate 🌟 At pitch sink, we’re dedicated to helping physicians bring their innovative ideas to life. Whether it’s groundbreaking products or new approaches to healthcare, we provide the resources and community to support their journey from concept to reality. From elite consulting talent to a thriving innovation network, we’ve got everything physician entrepreneurs need to thrive. 🚀 Learn more about our physician innovation programs. #physicians #medtech #innovation #pitchsink

“You've got to balance the idea that the doctors that first work with you are going to understand that they have technology that isn't complete, that this isn't the final generation. But you need to have developed it in such a way that there is a real path to that final version.” Dan Rose is back on Medsider to share his proven #medtech insights after LimFlow SA’s recent exit to Inari Medical. With 25 years of experience in both startups and industry giants like Medtronic, Dan talks about M&A transactions, engaging with investors while maintaining business autonomy, and the importance of developing your #medicaldevice with the average user in mind. LimFlow’s technology tackles Peripheral Artery Disease (PAD) and Chronic Limb-Threatening Ischemia (CLTI) – conditions where blocked arteries threaten limb viability and may potentially lead to amputation. Instead of trying to open blockages, LimFlow ingeniously reroutes blood flow through adjacent veins, restoring circulation and offering hope to patients who suffer from this disease. Here’s a sneak peek into his interview with Scott Nelson: ⚖️ Vet your potential investors carefully and consider how their involvement will impact your business operations, especially if there are multiple parties involved. Limit their influence on decision-making to maintain flexibility and control over your company's direction. 🥼 In the early development phases, design for the average user to maximize adoption rates. Always iterate towards simplicity and be prepared to pivot accordingly. And don't hold onto complex elements or features simply because they were part of the original plan. 💵 Understanding the reimbursement landscape and how your technology fits into that is crucial to progress your conversations with VCs. Research potential investors to ensure that they have the capacity to invest and that their interests match your company's focus. Click on the link in the comments section to follow Dan’s journey building and exiting LimFlow. This Medsider episode was brought to you by FastWave Medical, a hot IVL startup in the cardiovascular space. Don’t miss out on their next fundraise (more details in the comments). P.S. - We just launched Medsider Mentors Volume V, which is packed with insights and learnings from founders and CEOs of some of the most dynamic medical device and health technology startups in the world. Click the link in the comment section for this latest edition now available exclusively to our premium members.

BookDoctorsTime.com 😊 Finding doctors online and comparing their profiles in one place seems incredibly convenient. 👩⚕️👨⚕️  The feature allowing doctors to maintain patient history and print prescriptions for free is definitely a plus. 📋💊 It's amazing how BDT has been recognized by SMART FIFTY and NASSCOM among the top startups, and even featured on the front page of Sakal! 🚀📰 With 5000+ appointments already fixed and 100+ registered doctors, BDT seems to be making quite an impact in connecting patients and doctors effectively. Being pioneers since 2013 shows the dedication and innovation behind the platform! 🌟 CEO & Founder, ajaykalantri.myview.tech